MicroRNA-452 promotes tumorigenesis in hepatocellular carcinoma by targeting cyclin-dependent kinase inhibitor 1B

Molecular and Cellular Biochemistry

Volumn 389, Issue 1-2, 2014, Pages 187-195

  Zheng, Qingliang ^a   Sheng, Qing ^a   Jiang, Caiying ^a   Shu, Jianhong ^a   Chen, Jian ^a   Nie, Zuoming ^a   Lv, Zhengbing ^a   Zhang, Yaozhou ^a  

^a ZHEJIANG SCI TECH UNIVERSITY   (China)

Author keywords

CDKN1B; Hepatocellular carcinoma; microRNA 452; Proliferation; Tumorigenesis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; MESSENGER RNA; MICRORNA; MICRORNA 452; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HEPG2; CLINICAL ARTICLE; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TARGETING; S PHASE CELL CYCLE CHECKPOINT;

3' UNTRANSLATED REGIONS; APOPTOSIS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; G1 PHASE; HEK293 CELLS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICRORNAS; RNA, MESSENGER; S PHASE; UP-REGULATION;

EID: 84896545383     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1940-z     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Hou J, Lin L, Zhou W et al (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19:232-243
3. Kota J, Chivukula RR, O'Donnell KA et al (2009) Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137:1005-1017
4. Aravalli RN, Cressman EN, Steer CJ (2013) Cellular and molecular mechanisms of hepatocellular carcinoma: an update. Arch Toxicol 87:227-247
5. Zhi Q, Zhu J, Guo X et al (2013) Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage. Biomed Pharmacother 67:393-398
6. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455:58-63
7. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
8. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP (2008) The impact of microRNAs on protein output. Nature 455:64-71
9. Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105
10. Shenouda SK, Alahari SK (2009) MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev 28:369-378
11. Whittaker S, Marais R, Zhu AX (2010) The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29:4989-5005
12. Sun J, Lu H, Wang X, Jin H (2013) MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications. ScientificWorldJournal 2013:924206
13. Gu H, Guo X, Zou L, Zhu H, Zhang J (2013) Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma. Mol Cell Biochem 375:23-30
14. Zhang L, Yang L, Liu X et al (2013) MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways. Hepatology 57:1919-1930
15. Yau WL, Lam CS, Ng L et al (2013) Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process. PLoS ONE 8:e57882
16. Yang X, Liang L, Zhang XF et al (2013) MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting IL-6-Stat3 pathway. Hepatology 58:158-170
17. Dang Y, Luo D, Rong M, Chen G (2013) Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET. PLoS ONE 8:e61054
18. Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302:1-12 (Pubitemid 46096921)
19. He L, Thomson JM, Hemann MT et al (2005) A microRNA polycistron as a potential human oncogene. Nature 435:828-833 (Pubitemid 40839734)
20. Liu L, Chen K, Wu J et al (2013) Downregulation of miR-452 promotes stem-like traits and tumorigenicity of gliomas. Clin Cancer Res 19:3429-3438
21. Cobrinik D (2005) Pocket proteins and cell cycle control. Oncogene 24:2796-2809
22. van den Heuvel S, Dyson NJ (2008) Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 9:713-724
23. Fornari F, Gramantieri L, Ferracin M et al (2008) MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27:5651-5661
24. Tannapfel A, Grund D, Katalinic A et al (2000) Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma. Int J Cancer 89:350-355 (Pubitemid 30620288)
25. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79:551-555
26. Sherr CJ (1996) Cancer cell cycles. Science 274:1672-1677
27. Sandhu C, Slingerland J (2000) Deregulation of the cell cycle in cancer. Cancer Detect Prev 24:107-118 (Pubitemid 30427696)
28. Morishita A, Masaki T, Yoshiji H et al (2004) Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma. Hepatology 40:677-686 (Pubitemid 39265590)
29. Harper JW, Elledge SJ (1996) Cdk inhibitors in development and cancer. Curr Opin Genet Dev 6:56-64 (Pubitemid 26059052)
30. Fischer PM, Gianella-Borradori A (2003) CDK inhibitors in clinical development for the treatment of cancer. Expert Opin Investig Drugs 12:955-970 (Pubitemid 36722448)
31. Morishita A, Gong J, Deguchi A et al (2011) Frequent loss of p19INK4D expression in hepatocellular carcinoma: relationship to tumor differentiation and patient survival. Oncol Rep 26:1363-1368
32. Trang P, Wiggins JF, Daige CL et al (2011) Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther 19:1116-1122